Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920367 Jiangxi Xinganjiang Pharmaceutical Co Ltd BJSE:920367
53 GF Score
Price ¥25.28
GF Value ¥12.04
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Jiangxi Xinganjiang Pharmaceutical Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Jiangxi Xinganjiang Pharmaceutical Co Valuation Rank Related Terms

BJSE:920367
53GF Score
Jiangxi Xinganjiang Pharmaceutical Co Ltd BJSE:920367
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangxi Xinganjiang Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥25.28 is trading 110% above its estimated GF Value™ of ¥12.04. GuruFocus considers Jiangxi Xinganjiang Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for BJSE:920367:

  • Valuation Rank:
  • GF Value™: ¥12.04 vs. price of ¥25.28 (110% above fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the BJSE:920367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jiangxi Xinganjiang Pharmaceutical Co Business Description

Address No. 36 Yunzhang Road, Industrial Park, Jizhou District, Jiangxi Province, Ji'an City, CHN, 343000
Jiangxi Xinganjiang Pharmaceutical Co Ltd conducts research and development, production, and sales of chemical raw materials, chemical preparations, and Chinese patent medicines. The company's raw material medicine products are mainly calcium gluconate, zinc gluconate, ferrous gluconate, and other gluconate series raw material medicines. Its main chemical preparations are vitamin C chewable tablets and compound Yinqiao aminomin capsules, and Phenaminokamin Tablets.
53GF Score

Get the complete analysis for BJSE:920367

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥25.28
Price
¥12.04
GF Value